(Exact name of registrant as specified in its charter)

 

 

 

Registrant’s telephone number, including area code: (310) 212-7910

Securities registered pursuant to Section 12(b) of the Act:

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☑ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

 

There were 19,352,135 shares of Common Stock outstanding at August 4, 2025.

 

 

TABLE OF CONTENTS

 

 

 

 

The following terms are frequently used in the text of this report and have the meanings indicated below.

 

“Used Core” — An automobile part which has previously been used in the operation of a vehicle. Generally, the Used Core is an original equipment (“OE”) automobile part installed by the vehicle manufacturer and subsequently removed for replacement. Used Cores contain salvageable parts, which are an important raw material in the remanufacturing process. We obtain most Used Cores by providing credits to our customers for Used Cores returned to us under our core exchange programs. Our customers receive these Used Cores from consumers who deliver a Used Core to obtain credit from our customers upon the purchase of a newly remanufactured automobile part. When sufficient Used Cores are not available from our customers, we purchase Used Cores from core brokers, who are in the business of buying and selling Used Cores. The Used Cores purchased from core brokers or returned to us by our customers under the core exchange programs, and which have been physically received by us, are part of our raw material and work-in-process inventory. Used Cores returned by consumers to our customers but not yet returned to us are classified as contract assets until we physically receive these Used Cores.

 

“Remanufactured Core” — The Used Core underlying an automobile part that has gone through the remanufacturing process and through that process has become part of a newly remanufactured automobile part. The remanufacturing process takes a Used Core, breaks it down into its component parts, replaces those components that cannot be reused and reassembles the salvageable components of the Used Core and additional new components into a remanufactured automobile part. Remanufactured Cores held for sale at our customer locations are included in long-term contract assets. The Remanufactured Core portion of stock adjustment returns are classified as contract assets until we physically receive them.

 

PART I — FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Motorcar Parts of America, Inc. and its subsidiaries (the “Company”, or “MPA”) is a leading supplier of automotive aftermarket non-discretionary replacement parts, and test solutions and diagnostic equipment. These replacement parts are primarily sold to automotive retail chain stores and warehouse distributors throughout North America and to major automobile manufacturers for both their aftermarket programs and warranty replacement programs (“OES”). The Company’s test solutions and diagnostic equipment primarily serves the global automotive component and powertrain testing market. The Company’s products include (i) light duty and heavy duty rotating electrical products such as alternators and starters, (ii) wheel hub assemblies and bearings, (iii) brake-related products, which include brake calipers, brake boosters, brake rotors, brake pads, and brake master cylinders, and (iv) other products, which include (a) turbochargers and (b) test solutions and diagnostic equipment including: (i) applications for combustion engine vehicles, including bench-top testers for alternators and starters, (ii) equipment for the pre- and post-production of electric vehicles, and (iii) software emulation of power system applications for the electrification of all forms of transportation (including automobiles, trucks, the emerging electrification of systems within the aerospace industry, and electric vehicle charging stations).

 

 

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended June 30, 2025 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2026. This report should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended March 31, 2025, which are included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on June 9, 2025.

 

The accompanying condensed consolidated financial statements have been prepared on a consistent basis with, and there have been no material changes to the accounting policies described in Note 2, Summary of Significant Accounting Policies, to the consolidated financial statements that are presented in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

 

 

 

In October 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This standard was issued in response to the SEC’s disclosure update and simplification initiative, which affects a variety of topics within the Accounting Standards Codification. The amendments apply to all reporting entities within the scope of the affected topics unless otherwise indicated. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

 

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). This standard requires the Company to provide further disaggregated income tax disclosures for specific categories on the effective tax rate reconciliation, as well as additional information about federal, state/local and foreign income taxes. The standard also requires the Company to annually disclose its income taxes paid (net of refunds received), disaggregated by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard is to be applied prospective basis, although optional retrospective application is permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

 

 

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“DISE”) (Subtopic 220-40). This standard requires the Company to disclose, in the footnotes at each interim and annual reporting period, information about expenses by the nature of the expense in addition to certain disclosures about selling expenses. Entities are required to include the following relevant expense captions: (i) purchase of inventory, (ii) employee compensation, (iii) depreciation, (iv) intangible asset amortization, and (v) depreciation, depletion and amortization recognized as part of oil and gas producing activities. In January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) Clarifying the Effective Date, which is intended to clarify the effective date of ASU No. 2024-03. As clarified in ASU 2025-01, the new guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

 

 

In November 2024, the FASB issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which seeks to clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. This guidance is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

 

 

The Company has trade accounts receivable that result from the sale of goods and services. Accounts receivable — net includes offset accounts related to allowances for credit losses, customer payment discrepancies, and returned goods authorizations (“RGAs”) issued for in-transit unit returns. The Company uses accounts receivable discount programs with certain customers and their respective banks (see Note 10).

 

Accounts receivable — net is comprised of the following:

 

 

 

Inventory — net is comprised of the following:

 

 

 

During the three months ended June 30, 2025 and 2024, the Company reduced the carrying value of Remanufactured Cores held at customers’ locations by $1,026,000 and $394,000, respectively.

 

Contract assets are comprised of the following:

 

 

 

 

The largest customers accounted for the following percentage of consolidated net sales:

 

 

Revenues for these customers were derived from the Hard Parts segment and Test Solutions and Diagnostic Equipment segment. See Note 18 for a discussion of the Company’s segments.

 

The largest customers accounted for the following percentage of accounts receivable – trade:

 

 

 

The Company’s products are sold predominantly in North America and accounted for the following percentages of consolidated net sales:

 

 

 

The Company had no suppliers that accounted for more than 10% of inventory purchases for the three months ended June 30, 2025 and 2024.

 

 

The Company has $268,620,000 in senior secured financing, (as amended from time to time, the “Credit Facility”) consisting of a $238,620,000 revolving loan facility (the “Revolving Facility”), subject to certain restrictions, and a $30,000,000 term loan facility (the “Term Loans”). The Term Loans were repaid during the year ended March 31, 2024. The Credit Facility matures on December 12, 2028. The lenders have a security interest in substantially all of the assets of the Company.

 

The Company had $86,856,000 and $90,787,000 outstanding under the Revolving Facility at June 30, 2025 and March 31, 2025, respectively. In addition, $11,888,000 was outstanding for letters of credit at June 30, 2025. At June 30, 2025, after certain contractual adjustments, $134,341,000 was available under the Revolving Facility. The interest rate on the Company’s Revolving Facility was 7.40% and 7.46%, at June 30, 2025 and March 31, 2025, respectively.

 

The Credit Facility requires the Company to maintain a minimum fixed charge coverage ratio if undrawn availability is less than 22.5% of the aggregate revolving commitments and a specified minimum undrawn availability. During the three months ended June 30, 2025, undrawn availability was greater than the 22.5% threshold, therefore, the fixed charge coverage ratio financial covenant was not required to be tested.

 

 

On March 31, 2023, the Company entered into a note purchase agreement, as amended, (the “Note Purchase Agreement”) with Bison Capital Partners VI, L.P. and Bison Capital Partners VI-A, L.P. (collectively, the “Purchasers”) and Bison Capital Partners VI, L.P., as the purchaser representative (the “Purchaser Representative”) for the issuance and sale of $32,000,000 in aggregate principal amount of convertible notes due in 2029 (the “Convertible Notes”), which was used for general corporate purposes. The Convertible Notes bear interest at a rate of 10.0% per annum, compounded annually, and payable (i) in-kind or (ii) in cash, annually in arrears on April 1 of each year, commencing on April 1, 2024. In April 2025, non-cash accrued interest on the Convertible Notes of $3,521,000 was paid in-kind and is included in the principal amount of Convertible Notes at June 30, 2025. The Convertible Notes have an initial conversion price of $15.00 per share of the Company's common stock, subject to adjustment as provided in the Convertible Notes (“Conversion Option”). Unless and until the Company delivers a redemption notice, the Purchasers of the Convertible Notes may convert their Convertible Notes at any time at their option. Upon conversion, the Convertible Notes will be settled in shares of the Company’s common stock. Except in the case of the occurrence of a fundamental transaction, as defined in the form of convertible promissory note, the Company may not redeem the Convertible Notes prior to March 31, 2026. After March 31, 2026, the Company may redeem all or part of the Convertible Notes for a cash purchase (the “Company Redemption”) price. The effective interest rate was 18.3% as of June 30, 2025 and March 31, 2025, respectively.

 

The Company’s Convertible Notes are comprised of the following:

 

 

In connection with the Note Purchase Agreement, the Company entered into common stock warrants (the “Warrants”) with the Purchasers, which mature on March 30, 2029. The fair value of the Warrants, using Level 3 inputs and the Monte Carlo simulation model, was zero at June 30, 2025 and March 31, 2025.

 

The Company Redemption option has been combined with the Conversion Option as a compound net derivative liability (the “Compound Net Derivative Liability”). The Compound Net Derivative Liability has been recorded within convertible note, related party in the condensed consolidated balance sheets at June 30, 2025 and March 31, 2025. The fair value of the Conversion Option and the Company Redemption option using Level 3 inputs and the Monte Carlo simulation model was a liability of $12,900,000 and $9,000,000, and an asset of $3,640,000 and $1,530,000 at June 30, 2025 and March 31, 2025, respectively. During the three months ended June 30, 2025 and 2024, the Company recorded a loss of $1,790,000 and a gain of $2,580,000, respectively, as the change in fair value of the Compound Net Derivative Liability in the condensed consolidated statements of operations and condensed consolidated statements of cash flows.

 

 

Interest expense related to the Convertible Notes is as follows:

 

 

There are no future payments required under the Convertible Notes prior to their maturity, therefore, the principal amount of the Convertible Notes plus interest payable in-kind, assuming no early redemption or conversion has occurred, of $56,704,000 would be paid on March 30, 2029.

 

 

Contract liabilities are comprised of the following:

 

 

 

The Company leases various facilities in North America and Asia under operating leases expiring through August 2033. The Company has material nonfunctional currency leases that could have a material impact on the Company’s condensed consolidated statements of operations. As required for other monetary liabilities, lessees remeasure foreign currency-denominated lease liabilities using the exchange rate at each reporting date, but the lease assets are nonmonetary assets measured at historical rates and are not affected by subsequent changes in the exchange rates.  In connection with the remeasurement of these leases, the Company recorded a gain of $4,002,000 and a loss of $5,709,000 during the three months ended June 30, 2025 and 2024, respectively. These amounts are included in foreign exchange impact of lease liabilities and forward contracts in the condensed consolidated statements of operations.

 

During the year ended March 31, 2025, the Company ceased manufacturing operations at its Torrance, California facility as a part of its strategy to enhance its operating efficiencies. This represented a significant change to the use of this right-of-use asset, which required a reassessment of the Company’s asset groups. The Company concluded that this right-of-use asset was no longer part of the Hard Parts asset group. The Company performed a test for recoverability (using Level 3 inputs) which resulted in no impairment at June 30, 2025. Any future changes to the assumptions and estimates from those anticipated may affect the carrying value of right-of-use assets and could result in impairment charges.

 

Balance sheet information for leases is as follows:

 

 

Lease cost recognized in the condensed consolidated statements of operations is as follows:

 

 

Maturities of lease commitments at June 30, 2025 by fiscal year were as follows:

 

 

Other information about leases is as follows:

 

 

 

The Company uses accounts receivable discount programs offered by certain customers and their respective banks. Under these programs, the Company may sell those customers’ receivables to those banks at a discount to be agreed upon at the time the receivables are sold. These discount arrangements allow the Company to accelerate receipt of payment on customers’ receivables.

 

The following is a summary of accounts receivable discount programs:

 

 

 

The Company utilizes a supplier finance program, which allows certain of the Company’s suppliers to sell their receivables due from the Company to participating financial institutions at the sole discretion of both the supplier and the financial institutions. The program is administered by a third party. Commitments from participating financial institutions that are available to suppliers under this program were $30,000,000 at June 30, 2025 and March 31, 2025. The Company has no economic interest in the sale of these receivables and no direct relationship with the financial institution. Payments to the third-party administrator are based on services rendered and are not related to the volume or number of financing agreements between suppliers, financial institution, and the third-party administrator. The Company is not a party to agreements negotiated between participating suppliers and the financial institution. The Company's obligations to its suppliers, including amounts due and payment terms, are not affected by a supplier's decision to participate in this program. The Company does not provide guarantees and there are no assets pledged to the financial institution or the third-party administrator for the committed payment in connection with this program. At June 30, 2025 and March 31, 2025, the Company had $31,292,000 and $33,661,000, respectively, of outstanding supplier obligations confirmed as valid under this program, included in accounts payable in the condensed consolidated balance sheets.

 

 

Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Warrants, and Convertible Notes (as defined in Note 7), which would result in the issuance of incremental shares of common stock to the extent such impact is not anti-dilutive.

 

The following presents a reconciliation of basic and diluted net income (loss) per share:

 

 

Potential common shares that would have the effect of increasing diluted net income per share or decreasing diluted net loss per share are considered to be anti-dilutive and as such, these shares are not included in calculating diluted net income (loss) per share. For the three months ended June 30, 2025, there were 1,049,341 of potential common shares not included in the calculation of diluted net income per share because their effect was anti-dilutive. For the three months ended June 30, 2024, there were 2,285,834 of potential common shares not included in the calculation of diluted net loss per share because their effect was anti-dilutive.

 

In addition, for the three months ended June 30, 2025 and 2024, there were 2,646,535 and 2,405,941, respectively, of potential common shares not included in the calculation of diluted net income (loss) per share under the “if-converted” method for the Convertible Notes because their effect was anti-dilutive. The potential common shares related to the Warrants issued in connection with the Convertible Notes (see Note 7) are anti-dilutive until they become exercisable and as of June 30, 2025, the Warrants were not exercisable.

 

 

The Company recorded income tax expense of $2,425,000, or an effective tax rate of 44.4%, and income tax benefit of $178,000, or an effective tax rate of 1%, for the three months ended June 30, 2025 and 2024, respectively. The effective tax rate for the three months ended June 30, 2025, was primarily impacted by the change in valuation allowance on certain jurisdictions' deferred tax assets resulting from current year activities and foreign income taxed at rates that are different from the federal statutory rate.

 

Management continues to monitor its valuation allowance position in its various jurisdictions. In assessing the need for a valuation allowance, the Company considers all positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, past financial performance, and tax planning strategies. Based on this analysis, the Company determined that it is more likely than not that certain deferred tax assets will not be realized. As a result, the Company continued to have valuation allowances on its U.S. and one of its Mexican subsidiaries’ deferred tax assets. The Company will monitor its position in future periods. Should the actual amount differ from the Company’s estimates, the amount of any valuation allowance could be impacted.

 

The Company and its subsidiaries file income tax returns for the U.S. federal, various state, and foreign jurisdictions with varying statutes of limitations. At June 30, 2025, the Company remains subject to examination for fiscal years ended March 31, 2022 and forward. The Company believes no significant changes in the unrecognized tax benefits will occur within the next 12 months.

 

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law in the U.S. The OBBBA includes a broad range of tax reform provisions, including making permanent key elements of the Tax Cuts and Jobs Act of 2017, which may affect the Company's financial position and results of operations. The Company is currently evaluating the impact of these provisions on the Company's effective tax rate and deferred tax assets for future periods.

 

 

Purchases and expenses denominated in currencies other than the U.S. dollar, which are primarily related to the Company’s overseas facilities, expose the Company to market risk from material movements in foreign exchange rates between the U.S. dollar and the foreign currencies. The Company’s primary risk exposure is from fluctuations in the value of the Mexican peso and to a lesser extent the Chinese yuan. To mitigate these risks, the Company enters into forward foreign currency exchange contracts to exchange U.S. dollars for these foreign currencies. The extent to which forward foreign currency exchange contracts are used, is modified periodically in response to the Company’s estimate of market conditions and the terms and length of anticipated requirements.

 

The Company enters into forward foreign currency exchange contracts in order to reduce the impact of foreign currency fluctuations and not to engage in currency speculation. The use of derivative financial instruments allows the Company to reduce its exposure to the risk that the eventual cash outflow resulting from funding the expenses of the foreign operations will be materially affected by changes in exchange rates between the U.S. dollar and the foreign currencies. The Company does not hold or issue financial instruments for trading purposes. The Company designates forward foreign currency exchange contracts for forecasted expenditure requirements to fund foreign operations.

 

The Company had forward foreign currency exchange contracts with a U.S. dollar equivalent notional value of $42,531,000 and $45,921,000 at June 30, 2025 and March 31, 2025, respectively. These contracts generally have a term of one year or less, at rates agreed at the inception of the contracts. The counterparty to these derivative transactions is a major financial institution with investment grade credit rating; however, the Company is exposed to credit risk with this institution. The credit risk is limited to the potential unrealized gains (which offset currency fluctuations adverse to the Company) in any such contract should this counterparty fail to perform as contracted. Any changes in the fair values of forward foreign currency exchange contracts are included in foreign exchange impact of lease liabilities and forward contracts in the condensed consolidated statements of operations.

 

The following shows the effect of derivative instruments on the condensed consolidated statements of operations:

 

 

The changes in the fair values of forward foreign currency exchange contracts are included in foreign exchange impact of lease liabilities and forward contracts in the condensed consolidated statements of cash flows for the three months ended June 30, 2025 and 2024. The fair value of the forward foreign currency exchange contracts of $2,683,000 is included in prepaid expenses and other current assets in the condensed consolidated balance sheets at June 30, 2025. The fair value of the forward foreign currency exchange contracts of $1,663,000 is included in other current liabilities in the condensed consolidated balance sheets at March 31, 2025.

 

 

The following summarizes financial assets and liabilities measured at fair value, by level within the fair value hierarchy:

 

 

 

The Company’s short-term investments, which fund its deferred compensation liabilities, consist of investments in mutual funds. These investments are classified as Level 1 as the shares of these mutual funds trade with sufficient frequency and volume to enable the Company to obtain pricing information on an ongoing basis.

 

 

The forward foreign currency exchange contracts are primarily measured based on the foreign currency spot and forward rates quoted by the banks or foreign currency dealers (see Note 14).

 

 

The Company estimates the fair value of the Compound Net Derivative Liability (see Note 7) using Level 3 inputs and the Monte Carlo simulation model at the balance sheet date. The Monte Carlo simulation model requires the input of subjective assumptions including the expected volatility of the underlying stock. These subjective assumptions are based on both historical and other information. Changes in the values assumed and used in the model can materially affect the estimate of fair value. This amount is recorded within convertible notes, related party in the condensed consolidated balance sheets at June 30, 2025 and March 31, 2025. Any changes in the fair value of the Compound Net Derivative Liability are recorded in change in fair value of compound net derivative liability in the condensed consolidated statements of operations and condensed consolidated statements of cash flows.

 

The following assumptions were used to determine the fair value of the Compound Net Derivative Liability:

 

 

The following summarizes the activity for Level 3 fair value measurements:

 

 

During the three months ended June 30, 2025, the Company had no significant measurements of assets or liabilities at fair value on a nonrecurring basis subsequent to their initial recognition.

 

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair value due to the short-term nature of these instruments. The carrying amounts of the revolving loan and other long-term liabilities approximate their fair value based on the variable nature of interest rates and current rates for instruments with similar characteristics. At June 30, 2025 and March 31, 2025, the net carrying amount of the Convertible Notes was $40,844,000 and $35,207,000, respectively (see Note 7). The estimated fair value of the Company’s Convertible Notes was $51,514,000 and $42,398,000 using Level 3 inputs at June 30, 2025 and March 31, 2025, respectively.

 

 

 

During the three months ended June 30, 2025 and 2024, no options to purchase shares of the Company’s common stock were granted.

 

The following is a summary of stock option transactions:

 

At June 30, 2025, options to purchase 87,288 shares of common stock were unvested at a weighted average exercise price of $9.32.

 

At June 30, 2025, there was $201,000 of total unrecognized compensation expense related to unvested stock option awards, which will be recognized over the weighted average remaining vesting period of approximately 1.2 years.

 

 

During the three months ended June 30, 2025 and 2024, the Company granted 428,552 and 207,050, respectively, of time-based vesting RSUs, based on the closing market price on the grant date.

 

The following is a summary of non-vested RSUs:

 

 

At June 30, 2025, there was $5,931,000 of unrecognized compensation expense related to RSUs, which will be recognized over the weighted average remaining vesting period of approximately 2.7 years.

 

 

During the three months ended June 30, 2025, the Company granted 353,778 PSUs (at target performance levels) based on the Company’s stock price or a total shareholder return (“TSR”) market conditions. During the three months ended June 30, 2024, the Company granted 155,391 PSUs (at target performance levels), based on a TSR market condition. All PSUs granted have a three-year performance period, subject to continued employment.

 

 

During the three months ended June 30, 2025, the Company granted 176,893 PSUs (at target performance levels), which vest as follows: (i) if the stock price is greater than or equal to $15.00 per share, then 1/3 of the grant will vest, (ii) if the stock price is greater than or equal to $17.00 per share then the next 1/3 of the grant will vest, and (iii) if the stock price is greater than or equal to $20.00 per share then the final 1/3 of the grant will vest. Recipients are eligible to vest in between 50% and 150% of the third tranche by achieving a stock price between $18.00 and $22.00 per share (each stock price target must be met for thirty consecutive trading days). The Company calculated the fair value of these PSUs individually for each tranche using the Monte Carlo Simulation Model at the grant date. Compensation cost is recognized over the estimated derived service period. Compensation cost related to these awards will not be adjusted even if the market condition is not met.

 

During the three months ended June 30, 2024, the Company did not grant any PSUs based on the Company’s stock price.

 

 

During the three months ended June 30, 2025 and 2024, the Company granted 176,885 and 155,391 PSUs (at target performance levels), respectively, which cliff vest and the number of shares earned at the end of the three-year performance period will vary, based only on actual performance, from 0% to 150% of the target number of PSUs granted, depending on the Company’s TSR percentile rank relative to that of a peer group over the performance period. TSR is measured based on a comparison of the closing price on the first trading day of the performance period and the average closing price over the last 30 trading days of the performance period. TSR is considered a market condition because it measures the Company’s return against the performance of the Russell 3000, excluding companies classified as financials and real estate and companies with a market capitalization of more than $600 million, as of the start of the performance period. Compensation cost is determined at the grant date and recognized on a straight-line basis over the requisite service period to the extent the conditions are deemed probable. Compensation cost related to the TSR award will not be adjusted even if the market condition is not met.

 

The fair value of PSUs subject to a market condition is determined using the Monte Carlo simulation model. The following table summarizes the assumptions used in determining the fair value of the awards subject to market conditions:

 

 

The following is a summary of non-vested PSUs:

 

 

At June 30, 2025, there was $5,256,000 of unrecognized compensation expense related to these awards, which will be recognized over the weighted average remaining vesting period of approximately 2.2 years.

 

 

 

The Company allows its customers to return goods that their consumers have returned to them, whether or not the returned item is defective (“warranty returns”). The Company accrues an estimate of its exposure to warranty returns based on a historical analysis of the level of this type of return as a percentage of unit sales. Amounts charged to expense for these warranty returns are considered in arriving at the Company’s net sales.

 

The following summarizes the changes in the warranty returns:

 

 

At June 30, 2025 and March 31, 2025, the Company’s total warranty return accrual was $18,131,000 and $19,677,000, respectively, of which $7,222,000 and $6,478,000, respectively, was included in the customer returns RGA issued within accounts receivable—net and $10,909,000 and $13,199,000, respectively, was included in the customer finished goods returns accrual in the condensed consolidated balance sheets.

 

 

The Company is subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding the Company’s business, and its compliance with law, code, and regulations related to matters including, but not limited to, environmental, information security, taxes, levies, tariffs and such. The Company has an immaterial amount accrued related to these exposures to various lawsuits, claims, examinations, and administrative proceedings.

 

 

The Company has identified its Chief Executive Officer as its chief operating decision maker (“CODM”). The Company has identified its operating segments based on the nature of the products the Company sells, the Company’s organizational and management reporting structure, and the operating results that are regularly reviewed by the Company’s CODM to make decisions about the resources to be allocated to the business units and to assess performance. The CODM primarily uses operating income to evaluate the performance of the Company’s operating segments and to allocate resources.

 

The Company’s three operating segments are:

 

 

The Company’s Hard Parts operating segment meets the criteria of a reportable segment. The Test Solutions and Diagnostic Equipment and Heavy Duty segments are not material, and are not required to be separately reported.

 

Financial information relating to the Company’s segments is as follows:

 

 

 

 

 

In August 2018, the Company’s board of directors approved an increase in its share repurchase program from $20,000,000 to $37,000,000 of its common stock. During the three months ended June 30, 2025, the Company repurchased 197,796 shares of its common stock for $1,966,000. As of June 30, 2025, $25,543,000 has been utilized and $11,457,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in the Company’s Credit Facility and Convertible Notes. The Company retired the 1,576,937 shares repurchased under this program through June 30, 2025. The Company’s share repurchase program does not obligate it to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.

 

 

 

The Company has an operating lease for its 35,000 square foot manufacturing, warehouse, and office facility in Ontario, Canada, with a company co-owned by a member of management. The Company renewed this operating lease for an additional three-year period, effective January 1, 2025. The rent expense recorded for this related party lease was $93,000 and $81,000 for the three months ended June 30, 2025 and 2024, respectively.

 

 

In connection with the issuance and sale of the Company’s Convertible Notes on March 31, 2023 (see Note 7), the Board appointed Douglas Trussler, a co-founder of Bison Capital, to the Board. Mr. Trussler’s compensation is different from the compensation for other non-employee directors as described in the Company’s Definitive Proxy Statement, filed with the SEC on July 29, 2025.

 

 

The following discussion and analysis presents factors that Motorcar Parts of America, Inc. and its subsidiaries (“our,” “we” or “us”) believe are relevant to an assessment and understanding of our consolidated financial position and results of operations. This financial and business analysis should be read in conjunction with our March 31, 2025 audited consolidated financial statements included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on June 9, 2025.

 

 

This report may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our future performance that involve risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, but not limited to, statements about our strategic initiatives, operational plans and objectives, expectations for economic conditions and recovery and future business and financial performance, as well as statements regarding underlying assumptions related thereto. They include, among others, factors related to the timing and implementation of strategic initiatives, the highly competitive nature of our industry, demand for our products and services, complexities in our inventory and supply chain, challenges with transforming and growing our business. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Therefore, you should not place undue reliance on those statements. Please refer to “Item 1A. Risk Factors” of our most recent Annual Report on Form 10-K filed with the SEC on June 9, 2025, as updated by our subsequent filings with the SEC, for a description of these and other risks and uncertainties that could cause actual results to differ materially from those projected or implied by the forward-looking statements.

 

 

With a scalable infrastructure and abundant growth opportunities, we are focused on growing our aftermarket hard parts business in the North American marketplace and growing our leadership position in the test solutions and diagnostic equipment market by providing innovative and intuitive solutions to our customers. Our on-going investments in global infrastructure and human resources reflects the significant expansion of manufacturing capacity to support multiple product lines. These investments included (i) a 410,000 square foot distribution center, (ii) two buildings totaling 372,000 square feet for remanufacturing and core sorting of brake calipers, and (iii) the realignment of production at our original 312,000 square foot facility in Mexico.

 

 

Our three operating segments are as follows:

 

 

Our Hard Parts operating segment meets the criteria of a reportable segment. The Test Solutions and Diagnostic Equipment and Heavy Duty segments are not material, and are not required to be separately reported. See Note 18 of the notes to condensed consolidated financial statements for more information.

 

 

The following discussion and analysis should be read together with the financial statements and notes thereto appearing elsewhere herein.

 

The following summarizes certain key consolidated operating data:

 

 

 

 

The following summarizes net sales and gross profit:

 

 

Net Sales. Our consolidated net sales for the three months ended June 30, 2025 were $188,364,000, which represents an increase of $18,477,000, or 10.9%, from the three months ended June 30, 2024 of $169,887,000. Our sales for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 reflect continued strong demand for rotating electrical and brake-related products.

 

Gross Profit. Our consolidated gross profit was $33,917,000, or 18.0% of consolidated net sales, for the three months ended June 30, 2025 compared with $29,174,000, or 17.2% of consolidated net sales, for the three months ended June 30, 2024. The increase in our gross margin for the three months ended June 30, 2025 reflects (i) increased utilization of our facilities, (ii) the benefit from our strategies to enhance operating efficiencies and cost-saving initiatives, and (iii) changes in product mix. These increases were partially offset by $1,426,000 for net tariff costs paid for products sold before price increases were effective.

 

In addition, our gross margin for the three months ended June 30, 2025 compared with the three months ended June 30, 2024 was impacted by (i) continued amortization of core and finished goods premiums paid to customers of $2,847,000 and $2,728,000, respectively and (ii) the non-cash quarterly revaluation of cores that are part of the finished goods on the customers’ shelves (which are included in contract assets) to the lower of cost or net realizable value, which resulted in a write-down of $1,026,000 and $394,000, respectively.

 

 

The following summarizes our consolidated operating expenses:

 

 

General and Administrative. Our general and administrative expenses for the three months ended June 30, 2025 were $12,680,000, which represents a decrease of $3,990,000, or 23.9%, from the three months ended June 30, 2024 of $16,670,000. This decrease was primarily due to (i) a headcount reduction in the prior year, which resulted in $2,940,000 of severance during the three months ended June 30, 2024 and (ii) the benefit of favorable fluctuations in foreign currency exchange rates on transactions denominated in foreign currencies during the current year compared with the prior year.

 

Sales and Marketing. Our sales and marketing expenses for the three months ended June 30, 2025 were $6,210,000, which represents an increase of $761,000, or 14.0%, from the three months ended June 30, 2024 of $5,449,000. This increase was primarily due to increased commissions expense and increased headcount.

 

Research and Development. Our research and development expenses for the three months ended June 30, 2025 were $3,306,000, which represents an increase of $873,000, or 35.9%, from the three months ended June 30, 2024 of $2,433,000. This increase was primarily due to increased headcount, professional services, and supplies.

 

Foreign Exchange Impact of Lease Liabilities and Forward Contracts. Our foreign exchange impact of lease liabilities and forward contracts were a non-cash gain of $8,348,000 compared with a non-cash loss of $11,078,000 for the three months ended June 30, 2025 and 2024, respectively. This change during the three months ended June 30, 2025 compared with the three months ended June 30, 2024 was primarily due to (i) the remeasurement of our foreign currency-denominated lease liabilities, which resulted in a non-cash gain of $4,002,000 compared with a non-cash loss of $5,709,000, respectively, due to foreign currency exchange rate fluctuations and (ii) the forward foreign currency exchange contracts, which resulted in a non-cash gain of $4,346,000 compared with a non-cash loss of $5,369,000, respectively, due to the changes in their fair values.

 

 

Consolidated Operating Income (Loss). Our consolidated operating income for the three months ended June 30, 2025 was $20,069,000 compared with a consolidated operating loss of $6,456,000 for the three months ended June 30, 2024. This increase was primarily due to (i) our foreign exchange impact of lease liabilities and forward contracts, which were a non-cash gain of $8,348,000 compared with a non-cash loss of $11,078,000, (ii) increased gross profit, (iii) decreased general and administrative expenses, and (iv) other items as discussed above.

 

 

Interest Expense, net. Our interest expense for the three months ended June 30, 2025 was $12,812,000, which represents a decrease of $1,575,000, or 10.9%, from interest expense for the three months ended June 30, 2024 of $14,387,000. This decrease was primarily due to (i) lower average outstanding balances under our credit facility and (ii) lower interest rates on both our credit facility and accounts receivable discount programs.

 

 

Change in Fair Value of Compound Net Derivative Liability. Our change in fair value of compound net derivative liability associated with the convertible notes issued on March 31, 2023 was a non-cash loss of $1,790,000 compared with a non-cash gain of $2,580,000 for the three months ended June 30, 2025 and 2024, respectively.

 

 

Income Tax. We recorded an income tax expense of $2,425,000, or an effective tax rate of 44.4%, and income tax benefit of $178,000 or an effective tax rate of 1.0%, for the three months ended June 30, 2025 and 2024, respectively. The effective tax rate for the three months ended June 30, 2025, was primarily impacted by the change in valuation allowance on certain jurisdictions' deferred tax assets resulting from current year activities and foreign income taxed at rates that are different from the federal statutory rate.

 

 

 

We had working capital (current assets minus current liabilities) of $158,766,000 and $160,446,000, a ratio of current assets to current liabilities of 1.4:1.0 at June 30, 2025 and 1.5:1.0 at March 31, 2025.

 

Our primary source of liquidity was from cash generated from operations, the use of our receivable discount programs, and credit facility during the three months ended June 30, 2025. We believe our cash and cash equivalents, use of receivable discount programs, and amounts available under our credit facility are sufficient to satisfy our expected future liquidity needs, including lease and capital expenditure obligations over the next 12 months.

 

 

In August 2018, our board of directors approved an increase in our share repurchase program from $20,000,000 to $37,000,000 of our common stock. During the three months ended June 30, 2025, we repurchased 197,796 shares of our common stock for $1,996,000. As of June 30, 2025, $25,543,000 has been utilized and $11,457,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in our credit facility and convertible notes. We retired the 1,576,937 shares repurchased under this program through June 30, 2025. Our share repurchase program does not obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.

 

 

The following summarizes cash flows as reflected in the condensed consolidated statements of cash flows:

 

 

Net cash provided by operating activities was $10,028,000 compared with net cash used in operating activities of $20,841,000 during the three months ended June 30, 2025 and 2024, respectively. The changes in our operating activities were primarily due to (i) an increase in our accounts payable during the three months ended June 30, 2025 to support the build-up of our inventory in anticipation of higher sales compared with a decrease in our accounts payable during the three months ended June 30, 2024 and (ii) increased operating results (net income plus the net add-back for non-cash transactions in earnings). We continue to manage our working capital to maximize our operating cash flow.

 

Net cash used in investing activities was $806,000 and $512,000 during the three months ended June 30, 2025 and 2024, respectively. The change in our investing activities primarily resulted from increased capital expenditures.

 

Net cash used in financing activities was $6,778,000 compared with net cash provided by financing activities of $15,166,000 during the three months ended June 30, 2025 and 2024, respectively. The change in our financing activities were primarily due to (i) the net repayments of amounts outstanding under our revolving facility during the three months ended June 30, 2025 compared with net borrowing during the three months ended June 30, 2024 and (ii) the repurchase of 197,796 shares of our common stock for $1,966,000 during the three months ended June 30, 2025.

 

 

 

We have $268,620,000 in senior secured financing (as amended from time to time, the “Credit Facility”) consisting of a $238,620,000 revolving loan facility (the “Revolving Facility”), subject to certain restrictions, and a $30,000,000 term loan facility (the “Term Loans”). The Term Loans were repaid during the year ended March 31, 2024. The Credit Facility matures on December 12, 2028. The lenders have a security interest in substantially all of our assets.

 

We had $86,856,000 and $90,787,000 outstanding under the Revolving Facility at June 30, 2025 and March 31, 2025, respectively. In addition, $11,888,000 was outstanding for letters of credit at June 30, 2025. At June 30, 2025, after certain contractual adjustments, $134,341,000 was available under the Revolving Facility. The interest rate on our Revolving Facility was 7.40% and 7.46%, at June 30, 2025 and March 31, 2025, respectively.

 

The Credit Facility requires us to maintain a minimum fixed charge coverage ratio if undrawn availability is less than 22.5% of the aggregate revolving commitments and a specified minimum undrawn availability. During the three months ended June 30, 2025, undrawn availability was greater than the 22.5% threshold, therefore, the fixed charge coverage ratio financial covenant was not required to be tested.

 

 

On March 31, 2023, we entered into a note purchase agreement, as amended, (the “Note Purchase Agreement”) with Bison Capital Partners VI, L.P. and Bison Capital Partners VI-A, L.P. (collectively, the “Purchasers”) and Bison Capital Partners VI, L.P., as the purchaser representative (the “Purchaser Representative”) for the issuance and sale of $32,000,000 in aggregate principal amount of convertible notes due in 2029 (the “Convertible Notes”), which was used for general corporate purposes. The Convertible Notes bear interest at a rate of 10.0% per annum, compounded annually, and payable (i) in-kind or (ii) in cash, annually in arrears on April 1 of each year, commencing on April 1, 2024. In April 2025, non-cash accrued interest on the Convertible Notes of $3,521,000 was paid in-kind and is included in the principal amount of Convertible Notes at June 30, 2025. The Convertible Notes have an initial conversion price of $15.00 per share of the Company's common stock, subject to adjustment as provided in the Convertible Notes (“Conversion Option”). Unless and until we deliver a redemption notice, the Purchasers of the Convertible Notes may convert their Convertible Notes at any time at their option. Upon conversion, the Convertible Notes will be settled in shares of our common stock. Except in the case of the occurrence of a fundamental transaction, as defined in the form of convertible promissory note, we may not redeem the Convertible Notes prior to March 31, 2026. After March 31, 2026, we may redeem all or part of the Convertible Notes for a cash purchase (the “Company Redemption”) price. The effective interest rate was 18.3% as of June 30, 2025 and March 31, 2025, respectively.

 

In connection with the Note Purchase Agreement, we entered into common stock warrants (the “Warrants”) with the Purchasers, which mature on March 30, 2029. The fair value of the Warrants, using Level 3 inputs and the Monte Carlo simulation model, was zero at June 30, 2025 and March 31, 2025.

 

The Company Redemption option has been combined with the Conversion Option as a compound net derivative liability (the “Compound Net Derivative Liability”). The Compound Net Derivative Liability has been recorded within convertible note, related party in the condensed consolidated balance sheets at June 30, 2025 and March 31, 2025. The fair value of the Conversion Option and the Company Redemption option using Level 3 inputs and the Monte Carlo simulation model was a liability of $12,900,000 and $9,000,000, and an asset of $3,640,000 and $1,530,000 at June 30, 2025 and March 31, 2025, respectively. During the three months ended June 30, 2025 and 2024, we recorded a loss of $1,790,000 and a gain of $2,580,000, respectively, as the change in fair value of the Compound Net Derivative Liability in the condensed consolidated statement of operations and condensed consolidated statements of cash flows.

 

 

 

We use accounts receivable discount programs offered by certain customers and their respective banks. Under these programs, we have options to sell those customers’ receivables to those banks at a discount to be agreed upon at the time the receivables are sold. These discount arrangements allow us to accelerate receipt of payment on customers’ receivables. While these arrangements have reduced our working capital needs, there can be no assurance that these programs will continue in the future. Interest expense resulting from these programs would increase if interest rates rise, if utilization of these discounting arrangements expands, if customers extend their payment to us, or if the discount period is extended to reflect more favorable payment terms to customers.

 

The following is a summary of the accounts receivable discount programs:

 

 

 

We utilize a supplier finance program, which allows certain of our suppliers to sell their receivables due from us to participating financial institutions at the sole discretion of both the supplier and the financial institutions. The program is administered by a third party. Commitments from participating financial institutions that are available to suppliers under this program were $30,000,000 at June 30, 2025 and March 31, 2025. We have no economic interest in the sale of these receivables and no direct relationship with the financial institution. Payments to the third-party administrator are based on services rendered and are not related to the volume or number of financing agreements between suppliers, financial institution, and the third-party administrator. We are not a party to agreements negotiated between participating suppliers and the financial institution. Our obligations to our suppliers, including amounts due and payment terms, are not affected by a supplier's decision to participate in this program. We do not provide guarantees and there are no assets pledged to the financial institution or the third-party administrator for the committed payment in connection with this program. At June 30, 2025 and March 31, 2025, we had $31,292,000 and $33,661,000, respectively, of outstanding supplier obligations confirmed as valid under this program, included in accounts payable in the condensed consolidated balance sheets.

 

 

 

Our total capital expenditures were $2,708,000 and $493,000 for three months ended June 30, 2025 and 2024, respectively. These capital expenditures include (i) cash paid for the purchase of plant and equipment, (ii) plant and equipment acquired under finance leases, and (iii) non-cash capital expenditures. Capital expenditures for the three months ended June 30, 2025 primarily include the purchase of equipment for our current operations and our global growth initiatives. We expect to incur approximately $8,000,000 of capital expenditures primarily to support our global growth initiatives and maintenance of our facilities and equipment during fiscal 2026. We have used and expect to continue using our working capital and additional capital lease obligations to finance these capital expenditures.

 

 

 

We have an operating lease for our 35,000 square foot manufacturing, warehouse, and office facility in Ontario, Canada, with a company co-owned by a member of management. We renewed this operating lease for an additional three-year period, effective January 1, 2025. The rent expense recorded for this related party lease was $93,000 and $81,000 for the three months ended June 30, 2025 and 2024, respectively.

 

 

In connection with the issuance and sale of our Convertible Notes on March 31, 2023, the Board appointed Douglas Trussler, a co-founder of Bison Capital, to the Board. Mr. Trussler’s compensation is different from the compensation for other non-employee directors as described in our Definitive Proxy Statement, filed with the SEC on July 29, 2025.

 

 

 

 

There have been no material changes to our critical accounting policies and estimates that are presented in our Annual Report on Form 10-K for the year ended March 31, 2025, which was filed with the SEC on June 9, 2025.

 

 

 

In October 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This standard was issued in response to the SEC’s disclosure update and simplification initiative, which affects a variety of topics within the Accounting Standards Codification. The amendments apply to all reporting entities within the scope of the affected Topics unless otherwise indicated. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. We are currently evaluating the impact this guidance will have on our financial statement disclosures.

 

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). This standard requires us to provide further disaggregated income tax disclosures for specific categories on the effective tax rate reconciliation, as well as additional information about federal, state/local and foreign income taxes. The standard also requires us to annually disclose our income taxes paid (net of refunds received), disaggregated by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard is to be applied prospective basis, although optional retrospective application is permitted. We are currently evaluating the impact this guidance will have on our financial statement disclosures.

 

 

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“DISE”) (Subtopic 220-40). This standard requires us to disclose, in the footnotes at each interim and annual reporting period, information about expenses by the nature of the expense in addition to certain disclosures about selling expenses. Entities are required to include the following relevant expense captions: (i) purchase of inventory, (ii) employee compensation, (iii) depreciation, (iv) intangible asset amortization, and (v) depreciation, depletion and amortization recognized as part of oil and gas producing activities. In January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) Clarifying the Effective Date, which is intended to clarify the effective date of ASU No. 2024-03. As clarified in ASU 2025-01, the new guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the impact this guidance will have on our financial statement disclosures.

 

 

In November 2024, the FASB issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which seeks to clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. This guidance is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years, with early adoption permitted. We are currently evaluating the impact this guidance will have on our consolidated financial statements and disclosures.

 

 

There have been no material changes in market risk from the information provided in Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K as of March 31, 2025, which was filed with the SEC on June 9, 2025.

 

 

 

We have established disclosure controls and procedures designed to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management, including our chief executive officer, chief financial officer, and chief accounting officer, as appropriate to allow timely decisions regarding required disclosures.

 

Under the supervision and with the participation of management, including our chief executive officer, chief financial officer, and chief accounting officer, we have conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on this evaluation, our chief executive officer, chief financial officer, and chief accounting officer concluded that MPA’s disclosure controls and procedures were effective as of June 30, 2025.

 

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f).

 

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America, applying certain estimates and judgments as required.

 

Internal control over financial reporting includes those policies and procedures that:

 

1. Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

 

2. Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

 

3. Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that occurred during the three months ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

 

 

 

There have been no material changes in the risk factors set forth in Item 1A to Part I of our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 as filed with the SEC on June 9, 2025.

 

 

 

The Credit Facility currently permits the payment of up to $27,584,000 of dividends and share repurchases for fiscal year 2026, subject to pro forma compliance with amended financial covenants.

 

 

Shares repurchased during the three months ended June 30, 2025 were as follows:

 

 

 

None.

 

 

 

 

 

During the quarter ended June 30, 2025, the Company purchased 197,796 shares under Rule 10b5-1 trading arrangement. The adoption of a 10b5-1 trading arrangement allows the Company the ability to repurchase shares when it would be ordinarily restricted from purchases due to blackout periods or being in possession of material non-public information.

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 41

http://fasb.org/us-gaap/2025#RelatedPartyMember http://fasb.org/us-gaap/2025#RelatedPartyMember http://fasb.org/us-gaap/2025#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2025#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#AccountsPayableAndAccruedLiabilitiesCurrent 0.0033 0.0033 0.0033 0000918251 false 2026 Q1 --03-31 0000918251 2025-04-01 2025-06-30 0000918251 2025-08-04 0000918251 2025-06-30 0000918251 2025-03-31 0000918251 us-gaap:SeriesAPreferredStockMember 2025-06-30 0000918251 us-gaap:SeriesAPreferredStockMember 2025-03-31 0000918251 2024-04-01 2024-06-30 0000918251 us-gaap:CommonStockMember 2025-03-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000918251 us-gaap:RetainedEarningsMember 2025-03-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000918251 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000918251 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0000918251 us-gaap:CommonStockMember 2025-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000918251 us-gaap:RetainedEarningsMember 2025-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000918251 us-gaap:CommonStockMember 2024-03-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000918251 us-gaap:RetainedEarningsMember 2024-03-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000918251 2024-03-31 0000918251 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000918251 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000918251 us-gaap:CommonStockMember 2024-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000918251 us-gaap:RetainedEarningsMember 2024-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000918251 2024-06-30 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000918251 mpaa:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:ParentCompanyCreditAgreementMember 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:LoansPayableMember 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember 2025-04-01 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2025-03-31 0000918251 us-gaap:LetterOfCreditMember us-gaap:RevolvingCreditFacilityMember 2025-06-30 0000918251 us-gaap:RevolvingCreditFacilityMember 2025-06-30 0000918251 us-gaap:RevolvingCreditFacilityMember 2025-03-31 0000918251 us-gaap:ConvertibleDebtMember 2023-03-31 0000918251 us-gaap:ConvertibleDebtMember 2025-04-01 2025-06-30 0000918251 us-gaap:ConvertibleDebtMember 2025-06-30 0000918251 us-gaap:ConvertibleDebtMember 2025-03-31 0000918251 us-gaap:ConvertibleDebtMember 2024-04-01 2024-06-30 0000918251 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000918251 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2025-04-01 2025-06-30 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2024-04-01 2024-06-30 0000918251 us-gaap:ForeignExchangeForwardMember 2025-06-30 0000918251 us-gaap:ForeignExchangeForwardMember 2025-03-31 0000918251 srt:MaximumMember us-gaap:ForeignExchangeForwardMember 2025-04-01 2025-06-30 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2025-04-01 2025-06-30 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2024-04-01 2024-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleNotesPayableMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleNotesPayableMember 2025-03-31 0000918251 us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputCostOfEquityMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputCostOfEquityMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputWeightedAverageCostOfCapitalMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputWeightedAverageCostOfCapitalMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputEbitdaMultipleMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputEbitdaMultipleMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-04-01 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-04-01 2024-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2025-04-01 2025-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2025-06-30 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-06-30 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2025-04-01 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2024-04-01 2024-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-04-01 2025-06-30 0000918251 srt:MinimumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-04-01 2025-06-30 0000918251 srt:MaximumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-04-01 2025-06-30 0000918251 srt:MinimumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-06-30 0000918251 srt:MaximumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember 2024-04-01 2024-06-30 0000918251 mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2024-04-01 2024-06-30 0000918251 srt:MinimumMember mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2025-04-01 2025-06-30 0000918251 srt:MaximumMember mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2025-04-01 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2025-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2025-03-31 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0000918251 srt:MinimumMember us-gaap:PerformanceSharesMember 2025-04-01 2025-06-30 0000918251 srt:MaximumMember us-gaap:PerformanceSharesMember 2025-04-01 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2025-03-31 0000918251 mpaa:AccountsReceivableNetCurrentMember 2025-06-30 0000918251 mpaa:AccountsReceivableNetCurrentMember 2025-03-31 0000918251 mpaa:CustomerFinishedGoodsReturnsAccrualMember 2025-06-30 0000918251 mpaa:CustomerFinishedGoodsReturnsAccrualMember 2025-03-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:ExternalCustomersMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember mpaa:ExternalCustomersMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2024-04-01 2024-06-30 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-04-01 2025-06-30 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0000918251 us-gaap:IntersegmentEliminationMember 2025-04-01 2025-06-30 0000918251 us-gaap:IntersegmentEliminationMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-03-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2025-03-31 0000918251 us-gaap:IntersegmentEliminationMember 2025-06-30 0000918251 us-gaap:IntersegmentEliminationMember 2025-03-31 0000918251 us-gaap:CommonStockMember 2018-08-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2025-06-30 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2025-04-01 2025-06-30 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2024-04-01 2024-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure mpaa:Segment utr:sqft